Pharmaceutical Packaging: China
This report forecasts to 2023 pharmaceutical packaging demand in nominal US dollars at the manufacturer level in China. Total demand is segmented by product in terms of: plastic bottles; parenteral containers; blister packaging; prefillable inhalers; other primary containers such as glass bottles and jars, medication tubes, and pouches; closures; labels; packaging accessories; and secondary containers.
How will the COVID-19 coronavirus impact the global economy? The Freedonia Group is tracking recent developments and analyzing their impact in an easy to follow Economic Impact Tracker.
To illustrate historical trends, total demand is provided in annual series from 2008 to 2018; the various segments are reported at five-year intervals for 2008, 2013, and 2018.
For purposes of this report, pharmaceutical packaging product demand is defined as the value of finished containers, closures, and accessories sold by merchant companies and produced or assembled internally by pharmaceutical manufacturers and contract packaging firms.
Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.
Back to Top